Hans Ommen
7PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 14, 2026
Single-Cell Multi-Omics Identifies Measurable Residual Disease Targets Among Myelodysplasia- and Clonal Hematopoiesis-Related Genes in Acute Myeloid Leukemia.Emma Frasez Sørensen, Caroline Arvé, Jonas K Gronlund
|May 01, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.Jad Othman, Nicola Potter, Adam Ivey
|Feb 16, 2024
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Jad Othman, Nicola Potter, Adam Ivey
|Jan 10, 2024
Droplet digital PCR for sensitive relapse detection in acute myeloid leukaemia patients transplanted by reduced intensity conditioning.Jonas Kassow Gronlund, Christopher Veigaard, Caroline Juhl-Christensen
|Sep 27, 2023
Impaired fibrinolysis and increased clot strength are potential risk factors for thrombosis in lymphoma.Søren Thorgaard Bønløkke, Christian Fenger-Eriksen, Hans Beier Ommen
|Jun 17, 2022
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.Stéphane de Botton, Pau Montesinos, Andre C Schuh
Pageof 2
Frequent Collaborators
2 joint publications
Jonas Kassow Gronlund
2 joint publications
Jad Othman
2 joint publications
Nicola Potter
2 joint publications
Sylvie D Freeman
2 joint publications
Sean Johnson
2 joint publications
Joanna Canham
1 joint publications
Søren Thorgaard Bønløkke
1 joint publications
Christopher Veigaard
1 joint publications
Caroline Juhl-Christensen
1 joint publications
Anne-Sofie Skou
